Atlas Trials

Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers

Clinical trial NCT03662971 · COMPLETED

Trial details

NCT number
NCT03662971
Sponsor
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Corneal Defect
Start date
2018-10-29
Primary completion
2018-12-04
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.